Philip Brent Sheibley - 11 Dec 2025 Form 4 Insider Report for Modular Medical, Inc. (MODD)

Reporting relationship: Director
Issuer ticker: MODD
Reported as of: 11 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Dec 2025, 16:30:10 UTC
Prior SEC filing: 02 Oct 2025
Next SEC filing: 05 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ James Sullivan, attorney-in-fact for Philip Sheibley

Key filing fact

Philip Brent Sheibley filed Form 4 for Modular Medical, Inc. (MODD) on 15 Dec 2025.

Key facts

This page summarizes Philip Brent Sheibley's Form 4 filing for Modular Medical, Inc. (MODD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Dec 2025, 16:30.

Change

Previous filing in this sequence was filed on 02 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001895043 Primary reporting owner

Sheibley Philip Brent

Relationship: Director
Address: C/O MODULAR MEDICAL, INC., 10740 THORNMINT ROAD, SAN DIEGO,
Signature: /s/ James Sullivan, attorney-in-fact for Philip Sheibley
Signature date: 15 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MODD transaction

Common Stock

Award

Transaction value
Shares: +22,000
Change %: +29%
Price
Shares after: 97,513
Date: 11 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MODD transaction Derivative

Warrants to purchase Common Stock

Award

Transaction value
Shares: +11,000
Change %
Price
Shares after: 11,000
Date: 11 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,000
Exercise price: $0.4500
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On December 11, 2025, Reporting Person purchased in an underwritten public offering (a) 60,000 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") and (b) warrants (each, a "Warrant") to purchase 30,000 shares of Common Stock, at an offering price of $0.77 for each two shares of Common Stock and one Warrant.

Footnote F2

The Warrants were purchased by the Reporting Person from the Issuer in an underwritten public offering, were immediately exercisable and expire on the date that is five years from the date of issuance.

Footnote F3

In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Securities that have different exercise prices or vesting terms are not considered to be of the same "class."